$5 million cooperative agreement from the National Institutes of Health awarded to advance the development of its breakthrough non-invasive device, MyoRegulator™ for treatment of spasticity Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
To identify subgroups or strucutres in experimental data can be very challenging. Qlucore Omics Explorer is tailored to assist with this task in multiple ways. Read More
Flexion announces it has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203. Read More
Flexion announces initial findings from its ongoing Phase 3b, open-label study to evaluate the repeat administration of ZILRETTA™ Read More
Charles River Laboratories announced a new agreement which grants Charles River commercial access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure. Read More
CARB-X is seeking to partner with up to 6 additional accelerator organizations to expand its drug development and business support. Read More
Dr. Ole Isacson, M.D., Ph.D., a professor at Harvard Medical School, has been added to the Scientific Advisory Board at PathMaker Neurosystems. Read More